Altimmune Inc [NASDAQ: ALT] stock went on a downward path that fall over -7.17% on Thursday, amounting to a one-week price decrease of less than -10.20%.
Over the last 12 months, ALT stock dropped by -38.97%. The one-year Altimmune Inc stock forecast points to a potential upside of 76.71. The average equity rating for ALT stock is currently 1.60, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $356.87 million, with 81.11 million shares outstanding and 80.26 million shares in the current float. Compared to the average trading volume of 5.32M shares, ALT stock reached a trading volume of 9288617 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Altimmune Inc [ALT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALT shares is $18.89 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALT stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Altimmune Inc shares, keeping their opinion on the stock as Sell, with their previous recommendation back on Jul-11-25. While these analysts kept the previous recommendation, William Blair raised their target price to Mkt Perform. The new note on the price target was released on February 28, 2025, representing the official price target for Altimmune Inc stock. Previously, the target price had yet another raise to $18, while Stifel analysts kept a Buy rating on ALT stock.
The Price to Book ratio for the last quarter was 2.41, with the Price to Cash per share for the same quarter was set at 1.85.
ALT Stock Performance Analysis:
Altimmune Inc [ALT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.20. With this latest performance, ALT shares dropped by -26.05% in over the last four-week period, additionally sinking by -39.31% over the last 6 months – not to mention a drop of -38.97% in the past year of trading.
Insight into Altimmune Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Altimmune Inc [ALT] shares currently have an operating margin of -490965.00% and a Gross Margin at -700.00%. Altimmune Inc’s Net Margin is presently recorded at -451200.00%.
Return on Equity for this stock declined to -52.22%, with Return on Assets sitting at -52.22%.
ALT Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ALT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Altimmune Inc go to 2.73%.
Altimmune Inc [ALT] Institutonal Ownership Details
There are presently around $47.85%, or 48.22% of ALT stock, in the hands of institutional investors. The top three institutional holders of ALT stocks are: BLACKROCK INC. with ownership of 5.32 million shares, which is approximately 7.5025%. VANGUARD GROUP INC, holding 4.91 million shares of the stock with an approximate value of $$32.63 million in ALT stocks shares; and VANGUARD GROUP INC, currently with $$26.0 million in ALT stock with ownership which is approximately 5.5119%.
